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1. Introduction
1.1. General Overview
Fluorine occurs abundantly in nature as fluorspar and
fluoroapatite.[1] Despite these widespread natural resources,
only one enzyme exists that has been confirmed to be able to
perform fluorination: fluorinase. However, current research
suggests that there might be at least one more enzyme capable
of fluorination.[2] Perhaps surprisingly, among an estimated
number of 130000 natural products, there are only five
naturally occurring organofluorine compounds present in
plants, bacteria, or animals (Figure 1).[1, 2]
Fluoroacetate is the most common of the naturally
occurring organofluorine compounds and occurs in about
40, mostly poisonous plants in the southern and tropical
regions of Africa, Australia, and Brazil.[2, 3] Considering that
organofluorine compounds are almost absent in nature, it is
remarkable that 20 % of all pharmaceuticals and 30–40 % of
all agrochemicals contain fluorine.[4] The reason for this is
simple and can be clearly illustrated by considering the
toxicity of Dichapetalum cymosum.
For fluoroacetate, the C@F bond pre-
vents the conversion of this compound
into cis aconitate, and stops at the
2-fluorocitrate stage blocking the cit-
rate cycle.[3b] Their metabolic stability
and other unique physical, chemical,
and biological properties of organo-
fluorine compounds make them par-
ticularly interesting for the pharma-
ceutical and agricultural industries.[5]
These features make the monofluoro-
methyl group highly versatile as a bio-
isosteric unit for a series of functional
groups found in biological systems
(Figure 2).[6]
This bioisosterism, combined with
the enhanced metabolic stability, bio-
availability, lipophilicity, and mem-
brane permeability imparted by the
fluorine substituent, allows for effi-
cient drug design.[7] As a result, a vari-
ety of monofluoromethylated drugs
and inhibitors have been developed (Figure 3). For instance,
Afloqualone (6) is a muscle relaxant and sedative with clinical
use. Sevofluran (7) is a volatile anesthetic with great
significance in pediatric anesthesia because of its good
hypnotic but only weak analgesic and muscle-relaxing proper-
ties. Fluticasone propionateTM (8), a drug widely used against
inflammatory diseases and as an analgesic in the treatment of
certain cancers, is one of the industrially most important
drugs.[7b, 8] In addition to these well-established drugs, a num-
ber of inhibitors have also been tested.[6a,9]
Compound 9, is an inhibitor for the tumor suppressor
protein menin. The b-fluorinated amino acid 10 acts as so-
called “suicide substrate”, which can deactivate decarbox-
ylase enzymes and can be used against ParkinsonQs disease.
The androsta-1,4-diene-3,17-dione 11 acts as an aromatase
inhibitor and is suitable for the treatment of estrogen-
dependent diseases such as anovulatory infertility, prostate
hyperplasia, breast cancer, and many more.[6a, 9]
The compounds CH2FBr (HFBKW-31) and CH2FCl
(HFCKW-31) are frequently used on a large scale in industry
for synthesis[10] even though these compounds have high
ozone-depleting potentials.[11] As these substances are going
to be subject to successive banning under the Montreal
Protocol, and the handling of these chemicals will have to
The introduction of a monofluoromethyl moiety has undoubtedly
become a very important area of research in recent years. Owing to the
beneficial properties of organofluorine compounds, such as their
metabolic stability, the incorporation of the CH2F group as a bioiso-
steric substitute for various functional groups is an attractive strategy
for the discovery of new pharmaceuticals. Furthermore, the mono-
fluoromethyl unit is also widely used in agrochemistry, in pharma-
ceutical chemistry, and in fine chemicals. The problems associated with
climate change and the growing need for environmentally friendly
industrial processes mean that alternatives to the frequently used CFC
and HFBC fluoromethylating agents (CH2FCl and CH2FBr) are
urgently needed and also required by the Montreal Protocol. This has
recently prompted many researchers to develop alternative fluo-
romethylation agents. This Minireview summarizes both the classical
and new generation of fluoromethylating agents. Reagents that act via
electrophilic, nucleophilic, and radical pathways are discussed, in
addition to their precursors.
Figure 1. The five naturally occurring organofluorine compounds,
which are found in plants, animals or bacteria; a) Dichapetalum
cymosum, b) Streptomyces cattleya, c) Streptomyces calvus, d) Dichapae-
talum toxicarium.
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follow increasingly stricter rules,[11b] alternative fluoromethy-
lating agents are urgently needed. Although a fluoromethyl
group can be generated by introducing fluorine in place of
a suitable functional group[12] or by direct monofluorina-
tion,[13] the majority of synthetic procedures use a fluorome-
thylating agent instead, which can directly transfer a CH2F
group.[14] A further method starts with a precursor compound
that formally transfers a “CFR2” unit (R = SO2Ar or others)
to the substrate in the initial step, and subsequently gives the
desired CH2F group after work-up.
[7a] Fluoromethylation
chemistry developed before 2009 has been nicely reviewed
by Hu and co-workers.[7a] In addition, Review articles focusing
on fluorine-containing functional groups,[5b] difluoro- and
fluoromethylation,[14] transition-metal-mediated di- and mon-
ofluoroalkylations,[15] sulfur-based fluorination and fluoroal-
kylation reagents,[16] and on shelf-stable reagents for fluoro-
functionalization reactions[17] have been published. This
Minireview provides an overview over the reagents used for
the specific introduction of the CH2F group into organic
compounds. Classical monofluoromethylating agents as well
as newly developed reagents have been considered (Figure 4).
The literature has been covered until the end of 2019. The
reagents were classified by considering their ability to either
directly transfer the CH2F group in electrophilic, nucleophilic,
or radical fluoromethylation reactions, or to act as suitable
precursors generating CH2F after proper workup. The intro-
duction of CH2F moieties by transition-metal-mediated cross-
coupling reactions is discussed in the Section covering the
corresponding reagent.
1.2. A Historical Overview of Monofluoromethylating Reagents
The number of monofluoromethylating reagents has
almost doubled over the last ten years (Figure 4), reflecting
a dramatic development in this field. Particularly active in this
area has been the group of Hu, providing eight of these
reagents. Starting with simple compounds such as fluorome-
thanol and the fluoromethyl halides CH2FX (X = Cl, Br, I),
more sophisticated and efficient reagents applicable to
a broad range of substrates have been developed with time.
Efforts were focused on the introduction of better leaving
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Figure 2. Selected functional groups to which the -CH2F moiety is
bioisosteric.
Figure 3. Selected drugs and inhibitors containing a fluoromethyl
group.
Figure 4. Historical overview of monofluoromethylating reagents and
year of their first use as a CH2F transfer reagent.
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groups as compared to the halides and on fluoromethylating
reagents acting as nucleophiles—the generation of CH2FLi
being certainly a highlight—or reacting through a radical
pathway. Over the last ten years, in particular reagents and
synthetic protocols for radical fluoromethylation as well as for
CH2F introduction through transition-metal-mediated cross-
coupling—mainly, but not exclusively, based on fluoromethyl
halides—have been developed.
2. Reagents for Direct Monofluoromethylation
2.1. Electrophilic Monofluoromethylation
Fluoromethanol was the first reagent to be used for the
electrophilic introduction of CH2F. Olah and Pavlath report-
ed in 1953 the formation of fluoromethyl-substituted arenes
upon reaction with FCH2OH in the presence of a Lewis acid
(ZnCl2).
[18] Recently, it has been used for the fluoromethyla-
tion of special alcohols.[19]
2.1.1. Fluoromethyl Halides
The fluoromethyl halides CH2FX (X = Cl, Br, I) are all
volatile, which represents a challenge when using these
compounds. Nonetheless, this property is also an advantage
as this volatility allows for an excess of the reagent to be
readily separated from the product. In general, CH2FX
halides are weak fluoromethylating agents. Fluoromethyla-
tion through an SN2 reaction mechanism is more difficult than
the analogous methylation with a methyl halide.[5b, 20] The
a-fluorine effect is responsible for this behavior (Figure 5).[21]
A fluorine atom in the a-position stabilizes a positive
charge by p-donation. This effect is so strong that the
destabilizing inductive effect can effectively be ignored, and
an SN2 reaction can only take place if a good leaving group is
present at the CH2F moiety.
[21b,c] Thus, the reactivity of the
CH2FX halides increases in the order Cl<Br< I. However,
some reactions such as the electrophilic fluoromethylation of
carbon nucleophiles, as well as CH2F transfer to weak
nucleophiles, are problematic.[22] The fluoromethylating
strength of CH2FX can be increased considerably through
the presence of silver cations to bind the halide,[21b, 23] making
the fluoromethylation of weak nucleophiles such as NO3
@ [23]
and ClO4
@ [21b] possible. Initially, CH2FI (Orr,
[24] 1963) and
later CH2FBr (Lesuisse,
[25] 1992) and CH2FCl (Sundermey-
er,[26] 1985) was used for the fluoromethylation of a large
number of substrates.[25–27] The alkylation of a series of
oxygen, sulfur, nitrogen, and carbon nucleophiles by fluoro-
methyl halides has been described.[7a] Moreover, fluoromethyl
halides have often been used as starting materials for more
efficient fluoromethylating agents (Figure 6).[28] The first
fluoromethylated compounds acting as aromatase inhibitors,
or compounds with anabolic properties, were prepared using
CH2FI and CH2FBr.
[24, 25] A series of 18F-labeled fluoromethyl-
containing compounds that are frequently used for positron
emission tomography (PET) imaging have been prepared by
employing CH2
18FBr.[29] One of the most important applica-
tions of CH2FBr is its use in the last step of the synthesis of
FluticasoneTM,[30] which involves the fluoromethylation of
a thiocarboxylate precursor at the sulfur atom (Scheme 1).
Fluoroiodomethane[27c–e,31]] and the monosubstituted deriva-
tives CHRFI[27f,g] and CHRFBr[27f–h] have been used in several
cases to introduce a CH2F or CHRF group. The first
systematic studies on the fluoromethylation of phenols,
thiophenols, imidazoles, and indoles with CH2FCl (Scheme 2)
were reported in 2007 by Hu and co-workers.[5b, 22]
Over the last ten years, several transition-metal-mediated
fluoromethylation reactions starting from fluoromethyl hal-
ides CH2FX (X = Br, I) or carbon-monosubstituted deriva-
tives thereof have been developed (Scheme 3). All of these
syntheses involve C@C bond formation. Thus aryl boronic
esters or aryl boronic acids can be converted into the
corresponding fluoromethyl derivatives by coupling with
CH2FI, CH2FBr, or CHRFBr (R = CO2Et, SO2Ph) in Pd
0
(Suzuki,[27i] Hu,[27c] Qing[32]) CuI (Qing[27e]), or NiII (Zhang,[27b]
X.-S. Wang[27f]) catalyzed reactions, respectively. NiII in
combination with Mn has been used to promote the
introduction of CH2F (X.-S. Wang
[27a]) and CHRF (R = alkyl;
X.-S. Wang[27g]) into heteroarenes and arenes starting from
Figure 5. The a-fluorine effect.
Figure 6. Selected strong fluoromethylating agents derived from fluo-
romethyl halides and year of their first application as a CH2F transfer
reagent.
Scheme 1. Fluoromethylation step in the synthesis of FluticasoneTM.
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suitable heteroaryl bromides and aryl iodides by reductive
cross-coupling.
The CH(CO2Et)F group has been introduced in the para
(Zhao[33]) or meta position (G.-W. Wang,[27l] Ackermann[27m])
by RuII-catalyzed reactions of CH2F(CO2Et) with the corre-
sponding methoxyphenyl ketoximes or monosubstituted
arene derivatives, respectively. It has been shown by Wu
and co-workers[27m] that 8-aminoquinolines react with CHF-
(CO2Et)Br in the presence of Cu
II and HP(O)(OMe)2 to give
the corresponding CHF(CO2Et)-substituted derivatives.
It is noteworthy that the known fluoromethyl pseudoha-
lides CH2FX (X = CN,
[34] NCO,[35] N3
[36]) have not yet been
used as fluoromethylating agents.
2.1.2. Fluoromethyl Sulfonates
The fluoromethyl sulfonates 12a (Ali, 2014),[37] 12b
(Qianli, 2001),[28l] and 12 c (Iwata, 2002)[38] have been used
to introduce CH2F into a series of compounds at oxygen,
sulfur, or nitrogen atoms (Scheme 4).[7a] The main and most
important application of these reagents is in the synthesis of
18F-labeled fluoromethyl compounds to enable PET imag-
ing.[39] The fluoromethyl sulfonates 12a and 12b have been
prepared starting from bis(mesyloxy) and bis(tosyloxy)
methane and by introducing fluorine by reaction with KF.[40]
The synthesis of 12 b has been considerably improved[41] and is
almost quantitative when CsF in tert-amyl alcohol is used to
introduce fluorine.[12] Fluoromethyl triflate 12 c has been
obtained from CH2FBr and silver triflate,
[38,39b] albeit under
quite harsh reaction conditions.[28d] Since 2009, the use of
these reagents has greatly increased, and more non-18F-
labeled compounds have been synthesized in a targeted
manner.[28h, 42]
2.1.3. S-Monofluoromethyl Diarylsulfonium Tetrafluoroborate
In 2008, Prakash and Olah developed a powerful fluo-
romethylating agent that has been successfully applied in the
fluoromethylation of numerous nucleophiles (Scheme 5). The
fluoromethylsulfonium salt 13 is obtained in a three-step
synthesis with an overall yield of 60%.[28b] Interestingly, the
first step—the synthesis of the fluoromethyl phenyl thioeth-
er—is reported with better yields in the literature.[5b] The
sulfonium salt 13 is a moisture-insensitive solid; it is stable for
several months in the solid state and is also stable in
acetonitrile solution. However, in DMF and THF, decom-
position occurs.[28b]
Substrates that possess heteroatoms as nucleophilic
centers are readily fluoromethylated upon reaction with 13.
In particular, fluoromethyl sulfonates can be prepared under
mild conditions by using the sulfonium salt 13. However, its
application to carbon nucleophiles has thus far remained
limited to only a few compounds.[28b]
Scheme 2. Fluoromethylation of various O, N, and S nucleophiles with
CH2FCl.
Scheme 3. Transition-metal-mediated introduction of CH2F starting
from fluoromethyl halides and monosubstituted derivatives.
Scheme 4. Alkylation with fluoromethyl sulfonates.
Scheme 5. Fluoromethylation with 13.
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2.1.4. N,N-(Dimethylamino)-S-phenyl-S-monofluoromethyl Phenyl-
oxosulfonium Triflate
A very effective fluoromethylating reagent was developed
in 2011 by Shibata and co-workers.[43] It shows a pronounced
preference for fluoroalkylation at oxygen atoms, which
provides a synthetic approach for the preparation of mono-
fluoromethyl ethers. This method was applied to a number of
1,3-dicarbonyl compounds. It is a regioselective reagent for
b-keto esters and was successful also in the fluoromethylation
of carboxylic and sulfonic acids, oxindole derivatives, and
phenols, as well as naphthols (Scheme 6).[17, 43]
A disadvantage of this reagent is its tedious, multi-step
synthesis. However, when a modified procedure from the
literature is used to simplify the synthesis of the fluoromethyl
phenyl thioether intermediate,[44] the overall synthesis time
can be reduced substantially from almost 9 days to
1.5 days.[28b, 43] The reagent 14 is a solid that is easy to handle
and can be stored.[43] Although O-alkylation can also be
performed well with other reagents, the E/Z stereoselectivity
of 14 is particularly noteworthy. The O-regiospecificity of 14
was explained by a radical-like mechanism involving a SET
process.[45] However, Shen and co-workers reported that
alcohols did not react with this reagent under the conditions
applied.[28d]
2.1.5. Monofluoromethyl-Substituted Sulfonium Ylides
Completing the series of difluoromethyl- and trifluoro-
methyl-substituted sulfonium ylides, Shen and Lu reported in
2017 the missing monofluoromethyl sulfonium ylide 15, which
was structurally characterized by single-crystal X-ray diffrac-
tion. Reagent 15 is a stable solid and can be stored for at least
one month at ambient temperature on the bench without
notable decomposition, and it can be prepared in a straight-
forward manner in good yields.[28d]
The ylide 15 was found to be a very effective reagent for
the electrophilic fluoromethylation of primary, secondary,
and tertiary alcohols, as well as of malonic acid derivatives.[28d]
It was shown that 15 is a strong alkylating agent. Thus, the
conversion of sulfonic acids, carboxylic acids, phenols, amides,
and N-heteroarenes into the corresponding fluoromethyl
derivatives takes place readily under mild conditions
(Scheme 7).[28d]
Although 15 is a strong alkylating agent, reactions of 15
with carbon nucleophiles and C@CH2F bond formation are
problematic, and only proceed with special substrates.[28d]
2.2. Nucleophilic Monofluoromethylation
Because of their high instability, organometallic reagents
such as fluoromethyllithium or the corresponding Grignard
reagents belong to the most difficult areas of research on
nucleophilic monofluoromethylating agents.[7a] In 2017, Pace
and Luisi achieved a great breakthrough in this field. They
reported the generation and use of fluoromethyllithium,
which was the first and still remains the only direct
nucleophilic monofluoromethylation reagent (Scheme 8).[46]
In order to perform reactions with this unstable species, it is
important to stick strictly to the reaction conditions report-
ed,[46] as the generation of 16 only succeeds upon adding
MeLi·LiBr in a molar ratio of 2:1.5 to the substrate.
Furthermore, the reaction has to be quenched, and a solvent
mixture of THF/Et2O (1:1) has to be used.
[46] Unfortunately,
unlike MeLi, reagent 16 cannot be isolated at room temper-




Until about ten years ago, a free radical monofluorome-
thylation was unknown.[7a] In 2014, Hu and co-workers
described the sulfur-containing reagent 17, which is able to
transfer the fluoromethyl radical group to a substrate (Sche-
me 9).[28e, 47]
Various compounds were fluoromethylated at O, S, N, or P
in good yields by using sulfoximine 17. The range of
applications of 17 was extended by Akita and co-workers to
the C-fluoromethylation of alkenes by using strongly reducing
photoredox catalysts.[13a] Despite the time-consuming (3 days)
Scheme 6. O-Fluoromethylation of selected compounds.
Scheme 7. C-, N-, and O-fluoromethylation with sulfonium ylide 15.
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synthesis of 17 and the only moderate yield, an important
advantage of this reagent is its stability. At room temperature,
17 is a crystalline solid, which has been characterized by
single-crystal X-ray diffraction and does not decompose even
upon storage in air for one year.[47]
2.3.2. Fluoromethylsulfonyl Chloride
Concurrent with the development of sulfoximine 17, in
2014, Dolbier and co-workers developed a photoredox-cata-
lyzed tandem radical cyclization of N-aryl acrylamides to
form fluorinated 3,3-disubstituted 2-oxindoles using an iri-
dium catalyst and fluoromethylsulfonyl chloride as the CH2F
source (Scheme 10).[28j]
Sulfonyl chloride 18 (colorless oil) is readily obtained
from 4-chlorobenzyl thiol in three steps in excellent yield
(90 %). In the cases of N-phenyl acrylamide and electron-
deficient alkenes, instead of cyclization, a formal addition of
chlorine and CH2F to the C=C double bond takes place to
yield saturated derivatives with a terminal fluoromethyl
group (Scheme 10). The reaction is catalyzed by copper and
is induced by visible light. Both reactions also occur with
CHF2 or CF3 substituents in place of CH2F.
[28c] However,
although the yields of the fluoroalkylated products are good,
applications of this reagent still remain limited at the present
time.
2.3.3. Metal Fluoromethyl Sulfinates
In 2012, Fujiwara and Dixon described a radical fluoro-
methylation using the zinc fluoromethyl sulfinate 19a.[48] This
reagent enables the C@H functionalization of diverse hetero-
cycles by introducing a fluoromethyl group (Scheme 11).
In 2015, Hu and co-workers developed a large-scale
synthesis for sodium sulfinate 19b and used it for radical
monofluoromethylation reactions.[49] Later, in 2017, Liu and
co-workers demonstrated that sodium sulfinate 19 b is a suit-
able reagent for the transition-metal-free radical fluoroalky-
lation of isocyanides to form phenanthridines.[50] Coumarin
derivatives with a CH2F group have been prepared very
recently by Li and co-workers starting from alkoxynates by
a silver-catalyzed cascade monofluoromethylation with
19b.[51] The zinc sulfinate 19a has also been widely used for
the synthesis of bioactive compounds,[48] and is remarkable
because of its simple and straightforward synthesis. Com-
pound 19 a has been isolated as a colorless solid and is stable
at room temperature. However, the synthesis of the sodium
salt, starting from a heteroaryl sulfone, is much simpler.[49]
2.3.4. Monofluoromethyl Sulfones
In 2016, Hu and co-workers reported a visible-light-
induced photoredox synthesis of fluoromethyl-substituted
phenanthridines based on the reaction of suitable isocyanides
with fluoromethyl sulfone 20.[52] The high redox potential of
the fluoromethyl sulfone is essential for successful fluorome-
thylation, and an irradiation time of 48 h was required
(Scheme 12).[12–15, 17,53]
The fluoromethylating reagent 20 is isolated in the last
step in moderate yield as a colorless, air-stable solid, which
makes it easy to handle. Its overall synthesis, however,
includes several steps and requires the use of CH2FCl as the
source of the fluoromethyl group.[12–15, 17,53]
Scheme 9. Radical fluoromethylation of selected O, S, N, P com-
pounds with 17 and proposed reaction mechanism.
Scheme 10. Radical fluoromethylation of N-aryl acrylamides with 18.
Scheme 11. Free radical fluoromethylation of selected heterocycles.
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3. Indirect Monofluoromethylation
Because of the instability of organometallic fluoromethyl
reagents such as fluoromethyllithium, it is sometimes neces-
sary to use precursor compounds containing a functionalized
fluoromethyl group. After the transfer of the functionalized




In the 1980s, the monofluoromethylation of organic
compounds attracted increasing interest. Research in this
area was focused in particular on the development of mild
fluoroalkylating reagents, complementing the traditional
methods based on fluoromethyl halides. Palmer reported an
effective alternative reagent for the fluoromethylation of
carboxylic acids, namely the magnesium salt 21 (Sche-
me 13).[7a, 54] The key step involves the nucleophilic attack of
an intermediately generated fluoromethyl carbanion to the
imidazolide of the carboxylic acid. Thus, reagent 21 may be
viewed as a synthon of the unstable CH2F
@ anion. The
resulting b-keto a-fluoro esters give the corresponding
fluoromethyl ketones upon hydrogenation in good yields.
The starting fluoromalonate ester is readily prepared[54, 55] and
is nowadays commercially available. Fluoromalonate meth-
yl[55a] and ethyl[55b] ester have also been directly used in
fluoromethylation reactions. The formation of 21 (colorless
solid) is straightforward, although it comprises three steps.
Furthermore, despite intensive studies, it has not been
possible to use this reagent in enantioselective transforma-
tions.[7a]
3.1.2. Fluoromethyl Phenyl Sulfone and Related Compounds
Fluoromethyl phenyl sulfone (22) is a colorless solid that
was reported as far back as 1985 to form the corresponding
fluoromethylidene ylide, and it has been used to prepare
fluoroolefins in a Wittig-analogous reaction.[56] In 2006, Hu
and co-workers extended this methodology to formally
transfer the CH2F moiety, which is formed after cleavage of
the sulfonyl group (Scheme 14).[57] Thus starting from (R)-
(tert-butylsulfinyl)imines, primary a-fluoromethyl amines and
cyclic secondary a-fluoromethyl amines become readily
accessible with high stereoselectivity using this reagent. The
method was further extended by Fustero and co-workers to
include the synthesis of chiral fluoromethyl isoindolines[58]
and isoquinolines.[59] Hu and co-workers further successfully
utilized 22 for the stereoselective synthesis of a vicinal
fluoromethyl ethylene diamine.[60] Monofluoromethyl-con-
taining amides can also be prepared using 22 in a Ritter
reaction.[61] The reaction of sulfone 22 with 2-cyclohexanone
and acyclic a,b-unsaturated ketones proceeds both by addi-
tion to the carbonyl group as well as through a Michael
addition, and yields the corresponding fluoromethyl deriva-
tives after reductive cleavage of the sulfonyl group, as
reported by Hu and co-workers.[7a, 58, 59,62]
A carbanion with a fluorine atom directly bonded to the
negatively charged carbon atom can also be stabilized by
a sulfoxide group. Deprotonation of fluoromethyl phenyl
sulfoxide at the methylene group with LDA at @78 8C results
in the formation of a carbanion, which is moderately stable at
low temperatures. Reaction with aldehydes followed by
pyrolysis generates the corresponding fluoromethyl ketones
in moderate yields (Scheme 15).[63] An aromatic fluorome-
thylation with an a-fluoro-b-keto phenyl sulfone, acting as
Scheme 12. Metal-mediated radical fluoromethylation of isocyanides.
Scheme 13. Synthesis of fluoromethyl ketones using magnesium fluo-
romalonate 21. Scheme 14. Fluoromethylation with fluoromethyl phenyl sulfone 22.
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a soft nucleophile, has been reported by Hu and co-work-
ers.[62] The three-step synthesis involves the addition to
a benzyne generated in situ, followed by the reduction of
the keto group and the reductive cleavage (Na/Hg) of the
sulfonyl moiety.[62] In addition to the frequently used fluo-
romethyl phenyl sulfone 22, derivatives of 22, described by
Hu and co-workers in 2012–2014, with substituents at the
fluoromethyl carbon atom or the analogous fluoromethyl
TBS-sulfoxinimine have also been used to prepare the
corresponding fluoromethyl products (Scheme 15).[15, 27f, 64]
Some of the syntheses involve transition-metal-mediated
C@C coupling reactions.[15,27f, 64a,b] Finch and co-workers de-
scribed in 1988 the use of sulfoximine 26 as a nucleophilic
source for the fluoromethyl group. Its reaction with aldehydes
and ketones in the presence of a base proceeds with addition
to the C=O bond yielding the corresponding b-fluorosulfonyl
alcohols. The reductive cleavage of the sulfonyl substituent
with aluminum amalgam produces the respective fluorine-
substituted olefins together with the fluoromethyl alcohols. In
the case of R1 = H and R2 = 4-MeOC6H4, the fluoromethyl
alcohol is obtained in 57 % yield when sodium amalgam is
used (Scheme 15).[65]
3.1.3. Fluorobis(phenylsulfonyl)methane
Since the discovery of fluorobis(phenylsulfonyl)methane
(FBSM, 23) in 2006 by Hu/Shibata and co-workers and its
suitability as a fluoromethylating agent, a number of fluo-
romethylation reactions, including transition-metal-mediated
cross-couplings, have been performed.[17,28i, 66] The synthesis of
23 has also been improved. A convenient method for the
preparation of 23 is the reaction of fluoromethyl phenyl
sulfone (22) with phenylsulfonyl fluoride.[5c] Hu and Prakash
reported that FBSM acts as a nucleophilic fluoromethylating
reagent and undergoes addition reactions with epoxides,[66a]
aziridines,[62] a,b-unsaturated ketones,[62,67] alkynyl ketones,[62]
and benzynes.[62] Shibata and Prakash found 22 to be an
effective reagent in the palladium-catalyzed enantioselective
fluoromethylation of allylic acetates, imines, and a,b-unsatu-
rated ketones and esters.[5b, 67] Further, the fluoromethylation
of alcohols, alkyl halides, and a,b-unsaturated ketones with 23
(using a cinchona alkaloid derived catalyst) has been repor-
ted.[7a, 67b] Using an in situ formed iminium compound as the
catalyst, Wang et al. reported an enantioselective addition of
23 to enals.[68] In the last ten years, some research groups have
described the reaction of FBMS with aliphatic aldehydes
resulting in enantioselective fluoromethylation in the b-
position,[69] as well as the addition of FBMS to MBH
carbonates or acetates yielding the products of an enantio-
selective asymmetric allylic alkylation (Scheme 16).[70] Gou-
verneur and co-workers showed that the palladium-catalyzed
allylic alkylation reaction of 23 with Morita–Baylis–Hillmann
(MBH) carbonates (allyl carbonates) proceeds with high
regioselectivity.[71] The addition to alkyl and benzyl halides
also proceeds with high yields, as shown by Olah and co-
workers.[72] The fluoromethyl group is finally formed after
reductive cleavage of the sulfonyl substituents with Mg in
MeOH (Scheme 16).[70c,71–73] Instead of the palladium catalyst,
the combination of a cinchona alkaloid and FeCl2 or
a cinchona-catalyzed Mannich-type reaction can be used for
enantioselective monofluoromethylation (Shibata and co-
workers).[74] Furthermore, the addition of 23 to carbonyl
compounds,[69a] a,b-unsaturated carbonyl compounds,[75] and
functionalized alkynes[76] as well as the enantioselective
synthesis of tertiary allylic fluorides by iridium-catalyzed
allylic fluoromethylation with 23 have been described by the
groups of Hu, Vesely, and Hartwig.[77] Reductive cleavage of
the sulfonyl substituents to yield the corresponding fluoro-
methyl derivatives, as in the other examples discussed above,
was not reported.
The reaction of 23 with MBH carbonates (Toru and Tan)
proceeds with high enantio- and diastereoselectivity and
yields alcohols with a fluoromethyl group in g-position to the
OH group after workup.[74, 78] The introduction of a fluoro-
Scheme 15. Fluoromethylation with fluoromethyl phenyl sulfoxide and
fluoromethyl phenyl sulfone derivatives.
Scheme 16. Reactions of FBSM (23) with MBH carbonates.
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methyl group in Ibuprofen by using 23 in place of the methyl
group results in an increase in its inhibitory activity.[79] The
reaction of secondary amines with formaldehyde in the
presence of FBSM (Prakash et al., 2013) opens up a general
and straightforward synthetic route to b-fluoro ethyla-
mines.[80] Hu and co-workers reported in the same year that
starting from tertiary amines, further b-fluoro ethylamines
can be prepared by C@C coupling using 23 and diisopropyl
azodicarboxylate (DIAD) as the coupling reagent (Sche-
me 17).[77b]
In 2014, Ramos and Yang extended the addition reaction
of FBSM to enals, providing an enantioselective synthesis for
fluoroindane and fluorochromanol derivates (Scheme 18).[81]
Shibata and co-workers reported an efficient method for
preparing C2-aryl indoles with a fluoromethyl group at the
alkyl side chain starting from the corresponding aryl sulfonyl
derivatives and replacing the SO2Ar substituent by CH2F, by
utilizing 23 in the presence of a chiral phase transfer
catalyst.[82] Furthermore, the acetate group of allenyl acetates
can be replaced with a CH2F group by employing 23 (Ma and
Lu), yielding the corresponding fluoromethyl allenes
(Scheme 19).[83] FBSM is also the key reagent of a highly
selective two-step synthesis of functionalized monofluorome-
thylated allenes, reported by Shibata and co-workers.[84] In the
first step, 2-bromo-1,3-dienes react with FBSM in a palladi-
um-catalyzed nucleophilic substitution that selectively intro-
duces the fluorobis(phenylsulfonyl)methyl group directly
bonded to the allene skeleton. The following reductive
desulfonation (Mg, MeOH) gives the fluoromethyl allenes
in excellent (81–83 %) yields.[84]
An efficient synthesis of a-fluoromethyl alcohols has been
reported by Prakash and Olah in 2012, using the related
trimethylsilyl derivative 24. This reagent contains a SiMe3
group in place of the hydrogen atom of FBSM and is readily
prepared from 23 by deprotonation with NaH and subsequent
silylation with Me3SiCl (Scheme 20).
[85]
3.1.4. 2-Fluoro-1,3-benzothiole-1,1,3,3-tetraoxide
The cyclic version (FBDT) 25 of FBSM was reported in
2010 by Shibata and co-workers.[86] Reagent 25 is prepared
starting from the corresponding methylene-bridged deriva-
tive by fluorination with Selectfluor and formed as a colorless
solid. FBDT adds efficiently to the C=O group of a variety of
aldehydes yielding the corresponding a-fluoromethyl alco-
hols after workup. The addition is complete within 24 h. In the
case of a,b-unsaturated aldehydes, 1,2-addition competes
with 1,4-addition, and the selectivity is strongly dependent on
the base used (DABCO or pyrrolidone).[86] In the presence of
bifunctional cinchona alkaloid derived thiourea titanium
complexes, the reaction of 25 with aldehydes becomes
enantioselective (32–96% ee) and yields the fluoromethyl
alcohols in 73–91% yield (Scheme 21).[87] The structure of
Scheme 17. Synthesis of b-fluoro ethylamines using 23.
Scheme 18. Reaction of FBSM (23) with enals and enones.
Scheme 19. Synthesis of fluoromethyl-containing aryl-substituted in-
doles and allenes with 23.
Scheme 20. Synthesis of 24 and its use for the preparation of a-
fluoromethyl alcohols.
Scheme 21. Synthesis of 25 and its reaction with aldehydes.
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FBDT (25) has been determined in the solid state by single-
crystal X-ray diffraction.[86]
3.2. Phosphorus-Containing Fluoromethyl Precursors
Fluoromethyl triphenylphosphonium tetrafluoroborate
(27) has been utilized as a precursor to generate the
corresponding fluoromethylidene phosphonium ylide, which
has been employed in Wittig-type reactions for the synthesis
of fluoroalkenes. In the case of a special ketone (Scheme 22),
a subsequent proton shift catalyzed by trifluoroacetic acid
results in the formation of a fluoromethyl derivative (Bohl-
mann and co-workers, 1995).[9c,88] The structure of the
fluoromethyl triphenylphosphonium cation salt in the solid
state as its iodide salt has been determined by single-crystal
X-ray diffraction.[8]
The a-fluoromethyl phosphonate 28 displays increased
acidity for the proton in a-position, supported by the
electron-withdrawing sulfonyl group. Its reaction with form-
aldehyde (Takeuchi and co-workers, 1987) results in the
formation of the corresponding sulfonyl-substituted fluoroal-
kene, which can be converted with the anion of diethyl
acetamido malonate into the corresponding fluoromethyl
derivative after reductive elimination of the sulfonyl group
(Scheme 22).[89]
4. Conclusion
The unique properties of organic molecules containing
a fluoromethyl (CH2F) group and their use in various fields of
pharmacy and medicine has resulted in a high demand for
reagents that are capable of selectively introducing a CH2F
group. In recent decades, great efforts have been made in the
development of fluoromethylating reagents and several new
reagents have been prepared and used. Most of the reagents
are based on fluorohalomethanes and, more specifically,
fluorochloromethane, or derivatives thereof. The main syn-
thetic strategies are the introduction of a suitable leaving
group in place of the halogen (Cl, Br, I), or the introduction of
electron-withdrawing substituents at the carbon atom bonded
to fluorine. In the former case, the CH2F group is transferred
as the electrophile. The alkylation strengths of the reagents
differ and can be fine-tuned by the nature of the respective
leaving group. In the latter case, electron-withdrawing
substituents (SO2Ar, PhCH2OC(O), PhS(O)NTBS) stabilize
a negative charge at the carbon atom bonded to fluorine, and
CH2F is introduced as a nucleophile; the reagent can thus be
considered as a replacement for the unstable and very
sensitive FCH2Li. Over the last decade, particular attention
has been paid to reagents that are able to transfer the CH2F
group by a radical pathway. The strategy behind this approach
was again the introduction of suitable substituents at the
carbon atom bonded to fluorine that favor radical formation.
Despite the great progress that has been made, most of the
reagents are effective in transferring CH2F only to heteroa-
toms (nitrogen, oxygen, sulfur). The transfer of CH2F with
concurrent C@C bond formation is less effective, and the
development of readily available fluoromethylating reagents
capable of achieving this goal still remains a challenge for
organofluorine chemists.
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